Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Eastman Chemical updates financial calendar for Q3 2026 results release and webcast call

Eastman Chemical updates financial calendar for Q3 2026 results release and webcast call

BitgetBitget2026/10/06 14:00

Eastman set its Q3 2026 financial results release for Thursday, Oct. 29, 2026, around 4:15 p.m. ET. Advance slides, webcast, teleconference scheduled for Friday, Oct. 30, 2026, at 8:00 a.m. ET via Eastman Q3 2026 Webcast. Teleconference pre-registration available ahead of the Oct. 30 call at https://events.q4inc.com/analyst/652847425?pwd=0MK9YrIb. Telephone replay runs from about 1:00 p.m. ET Oct. 30 through 11:59 p.m. ET Nov. 10, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eastman Chemical Company published the original content used to generate this news brief via Business Wire (Ref. ID: 20261006237378) on October 06, 2026, and is solely responsible for the information contained therein.

  • Eastman set its Q3 2026 financial results release for Thursday, Oct. 29, 2026, around 4:15 p.m. ET.
  • Advance slides, webcast, teleconference scheduled for Friday, Oct. 30, 2026, at 8:00 a.m. ET via Eastman Q3 2026 Webcast.
  • Teleconference pre-registration available ahead of the Oct. 30 call at https://events.q4inc.com/analyst/652847425?pwd=0MK9YrIb.
  • Telephone replay runs from about 1:00 p.m. ET Oct. 30 through 11:59 p.m. ET Nov. 10, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eastman Chemical Company published the original content used to generate this news brief via Business Wire (Ref. ID: 20261006237378) on October 06, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Former BioNTech executive leads Bambusa Therapeutics (BBTX.US) in sprint to Nasdaq, "boosting" eczema drug trials

Bambusa Therapeutics Inc. has filed for an initial public offering, planning to raise funds for clinical trials of treatments for eczema and other inflammatory diseases.

智通财经•2026/10/10 06:21